Dexamethasone pulse therapy in patients of systemic sclerosis: Is it a viable proposition? A study from kashmir
<b>Background:</b> Systemic sclerosis is a multisystemic autoimmune disorder. Intravenous dexamethasone pulse therapy has been used since 1998. <b>Aim:</b> The aim was to report the beneficial effects of dexamethasone pulse in patients of systemic sclerosis vis-á-v...
Saved in:
Main Authors: | Sameem Farah (Author), Hassan Iffat (Author), Ahmad Qazi (Author), Khan Dilshad (Author), Majeed Imran (Author), Kamili M (Author), Shah Parvaiz (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2010-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Increased incidence of tuberculosis in patients of systemic sclerosis on dexamethasone pulse therapy: A short communication from Kashmir
by: Ahmad Qazi, et al.
Published: (2008) -
Hirsutism in Kashmir: An etiological study
by: Ahmad Qazi, et al.
Published: (2009) -
Cardiac involvement in patients of systemic sclerosis
by: Ahmad Qazi, et al.
Published: (2008) -
Low dose penicillamine in systemic sclerosis: is it effective?
by: Farah Sameem, et al.
Published: (2012) -
Serum Lipid Profile In Leprosy Patients In Kashmir Valley
by: Ahmad Qazi Masood, et al.
Published: (2002)